🔥Hot off the press: @EMPHARM_NET study of 233 ED patients w/ pyelonephritis:
💉40% received IV antibiotics
💊 most common PO ABx: cephalexin, ciprofloxacin, cefdinir, & TMP-SMX
🦠Inactive therapy rate 10.3% & IV ABx ⬇️ odds of inactive therapy
https://t.co/zcRXAoYMOk
🚑🚨VERY exciting news for EM PharmDs:
We are forming the Academic EM Pharmacist Interest Group within SAEM
See the link for how to join, leadership, networking, resident opportunities, & more!
We need your help to make it a success! 🙌 #TwitteRx
https://t.co/w6YfjZATsG
Thrilled to have @AbbyMBaileyEM kick off day 2 of the #EMPRx22 conference! So many more great sessions coming your way today.
*see https://t.co/lq3rmQjRco for session changes at 1:30, 4:30, and 5:30 pm EST
Interested in joining a fun EM pharmacy team that loves all things academia? Check out our new job posting at the University of Iowa. DM with any questions.
https://t.co/dNyToyyRJa
🚨PGY2 EM Pharmacy Residency Open House🚨
💰FREE and virtual
📈Fill out the quick survey via link or QR code below to register!
📩Zoom Meeting info will be emailed after registration
https://t.co/CW80YVt0Fj
🚨Interested in a PGY2 Emergency Medicine Residency?🚨
Learn more about our program here at @UVMMedCenter during a free virtual open house!💊
Register using the link or QR code below:
https://t.co/CW80YVt0Fj
🚨Check our first group publication! 🚨
Staying InformED: Top emergency medicine pharmacotherapy articles of 2020 https://t.co/xebTeuOEcU
Highlights:
🔷TXA
🔷Ketamine vs. etomidate
🔷Stroke
🔷All things EM ID!
#TwitteRx@DEZ_EM_Pharm@MeganARech@bfaine1
We’re so excited to announce the Emergency Medicine PHARMacotherapy research NETwork (EMPHARM-NET)! Our goal is to foster and conduct high quality, transformative, multidisciplinary research pertaining to pharmacotherapy in EM patients across the US 🚨🚑💊 #TwitteRx
Two EM PharmD positions at MUSC in Charleston, SC!! Looking for some great people to join a fabulous team! @Tribidibidy@CMageePharmD @EMPharmD2B
https://t.co/fERsCX1W0e